Eko Stock
Eko creates FDA approved software, AI, and heart sound and EKG sensors for heart disease monitoring.
Sign up today and learn more about Eko Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Eko Stock
Eko Devices harnesses the power of smartphones and cloud data for monitoring patients with cardiovascular diseases. It has built a platform of non-invasive cardiovascular monitoring devices, clinical software, and point-of-care decision support algorithms to improve the delivery of cardiovascular care. In 2015, Eko launched the Eko Core Digital Stethoscope, the first FDA-cleared digital stethoscope on the market to wirelessly stream heart and lung sounds to HIPAA-compliant software. For the first time in history, patient sounds can be integrated with electronic health records (EHRs) for more seamless referrals, documentation, and monitoring. Eko Devices was established in 2013 and is based in Berkeley, California.
Funding History
| January 2014 | $800K |
|---|---|
| January 2015 | $0 |
| March 2015 | $2.0M |
| March 2018 | $5.0M |
Management
Co-Founder & CTO
Tyler Crouch
VP of Products
Philip Goolkasian
Co-Founder & COO
Jason Bellet
Co-Founder & CEO
Connor Landgraf
Press
prnewswire - Nov, 8 2023
Eko Health Announces Large-Scale Deployment of AI Heart Disease Detection Technologympo-mag - Sep, 26 2023
Astellas, Eko Health Collaborate on Heart Failure Detection Techbiospace - Sep, 5 2023
FIGS and Eko Health Collaborate on the FIGS | Eko CORE 500™ Digital Stethoscopebiospace - Jul, 18 2023
Astellas and Eko Health Announce Agreement to Incorporate Next Generation Eko CORE 500™ Digital Stethoscopeift - Feb, 25 2023
Eko lands $3.6m to support micro-entrepreneursEquityZen Recognized As:
